𝔖 Bobbio Scriptorium

✦ LIBER ✦

Gefitinib does not improve survival when combined with gemcitabine and cisplatin in people with advanced non-small-cell lung cancer: Abstracted from: Giaccone G, Herbst RS, Manegold C et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 1. J Clin Oncol 2004;22:777–784.

Book ID: 116394916
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 212 KB
Volume: 30
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2004.08.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib does not improve survival when

Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer: Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.

✍ W.K. (Bill) Evans 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Paclitaxel plus cisplatin is as effectiv

Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer: Abstracted from: Smit EF, van Meerbeeck JP, Lianes P, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 2003;21:3909–17.

✍ Sarah Danson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB